Display options
Cite
Vraka C, Pichler V, Berroterán-Infante N, et al. Optimization of the Automated Synthesis of [11C]mHED-Administered and Apparent Molar Activities. Pharmaceuticals (Basel). 2019;12(1)doi: 10.3390/ph12010012.
Vraka, C., Pichler, V., Berroterán-Infante, N., Wollenweber, T., Pillinger, A., Hohensinner, M., Fetty, L., Beitzke, D., Li, X., Philippe, C., Pallitsch, K., Mitterhauser, M., Hacker, M., & Wadsak, W. (2019). Optimization of the Automated Synthesis of [11C]mHED-Administered and Apparent Molar Activities. Pharmaceuticals (Basel, Switzerland), 12(1), . https://doi.org/10.3390/ph12010012
Vraka, Chrysoula, et al. "Optimization of the Automated Synthesis of [11C]mHED-Administered and Apparent Molar Activities." Pharmaceuticals (Basel, Switzerland) vol. 12,1 (2019). doi: https://doi.org/10.3390/ph12010012
Vraka C, Pichler V, Berroterán-Infante N, Wollenweber T, Pillinger A, Hohensinner M, Fetty L, Beitzke D, Li X, Philippe C, Pallitsch K, Mitterhauser M, Hacker M, Wadsak W. Optimization of the Automated Synthesis of [11C]mHED-Administered and Apparent Molar Activities. Pharmaceuticals (Basel). 2019 Jan 14;12(1). doi: 10.3390/ph12010012. PMID: 30646635; PMCID: PMC6469290.
Copy Download .nbib Format: NLM
Share it on

Pharmaceuticals (Basel). 2019 Jan 14;12(1). doi: 10.3390/ph12010012.

Optimization of the Automated Synthesis of [11C]mHED-Administered and Apparent Molar Activities.

Pharmaceuticals (Basel, Switzerland)

Chrysoula Vraka, Verena Pichler, Neydher Berroterán-Infante, Tim Wollenweber, Anna Pillinger, Maximilian Hohensinner, Lukas Fetty, Dietrich Beitzke, Xiang Li, Cecile Philippe, Katharina Pallitsch, Markus Mitterhauser, Marcus Hacker, Wolfgang Wadsak

Affiliations

  1. Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090Vienna, Austria. [email protected].
  2. Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090Vienna, Austria. [email protected].
  3. Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090Vienna, Austria. [email protected].
  4. Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090Vienna, Austria. [email protected].
  5. Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090Vienna, Austria. [email protected].
  6. Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090Vienna, Austria. [email protected].
  7. Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090Vienna, Austria. [email protected].
  8. Department of Biomedical Imaging and Image-guided Therapy, Division of Cardiovascular and Interventional Radiology, Medical University of Vienna, 1090 Vienna, Austria. [email protected].
  9. Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090Vienna, Austria. [email protected].
  10. Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090Vienna, Austria. [email protected].
  11. Institute of Organic Chemistry, University of Vienna, Vienna 1090, Austria. [email protected].
  12. Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090Vienna, Austria. [email protected].
  13. Ludwig-Boltzmann-Institute Applied Diagnostics, Vienna 1090, Austria. [email protected].
  14. Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090Vienna, Austria. [email protected].
  15. Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090Vienna, Austria. [email protected].
  16. Center for Biomarker Research in Medicine, CBmed GmbH, 8010 Graz, Austria. [email protected].

PMID: 30646635 PMCID: PMC6469290 DOI: 10.3390/ph12010012

Abstract

The tracer

Keywords: Keywords: [11C]meta-hydroxyephedrine; apparent molar activity; radiosynthesis; separation

References

  1. J Neural Transm (Vienna). 2002 Oct;109(10):1229-40 - PubMed
  2. Ann Surg Oncol. 2006 Feb;13(2):187-97 - PubMed
  3. J Nucl Med. 2010 Aug;51(8):1269-76 - PubMed
  4. Radiology. 2013 Apr;267(1):26-44 - PubMed
  5. J Nucl Med. 1990 Aug;31(8):1328-34 - PubMed
  6. Mol Metab. 2013 Apr 21;2(3):153-60 - PubMed
  7. Curr Radiopharm. 2014;7(2):79-83 - PubMed
  8. Int J Clin Exp Med. 2014 Dec 15;7(12):5541-6 - PubMed
  9. EJNMMI Res. 2015 Dec;5(1):113 - PubMed
  10. Adipocyte. 2014 Nov 14;4(1):1-12 - PubMed
  11. J Nucl Med. 2015 Sep;56(9):1429-33 - PubMed
  12. Nucl Med Biol. 2018 Feb;57:28-33 - PubMed
  13. Magn Reson Med. 2018 Dec;80(6):2641-2654 - PubMed
  14. Sci Rep. 2018 Jul 24;8(1):11120 - PubMed
  15. Nucl Med Biol. 1995 Feb;22(2):235-9 - PubMed

Publication Types